Eszopiclone-induced parasomnia with suicide attempt: A case report

Innovations in Clinical Neuroscience

Volumn 13, Issue 9-10, 2016, Pages 44-48

  Gibson Pennington, J ^a   Guina, Jeffrey ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Benzodiazepinelike; Drug reaction; Eszopiclone; Hypnotic; Insomnia; Parasomnia; Sedative

Indexed keywords

ESZOPICLONE; SERTRALINE;

ABNORMAL BEHAVIOR; ADULT; ARTICLE; BEDTIME DOSAGE; CASE REPORT; DEPRESSION; DRUG INDUCED DISEASE; HUMAN; MALE; MIDDLE AGED; PARANOIA; PARASOMNIA; SUICIDE ATTEMPT;

EID: 85006354992     PISSN: 21588333     EISSN: 21588341     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Canaday BR. Amnesia possibly associated with zolpidem administration. Pharmacotherapy. 1996;16(4):687–689.
2. Harazin J, Berigan TR. Zolpidem tartrate and somnambulism. Mil Med. 1999;164(9):669–670.
3. Sattar SP, Ramaswamy S, Bhatia SC, Petty F. Somnambulism due to probable interaction of valproic acid and zolpidem. Ann Pharmacother. 2003;37(10):429–1433.
4. Gibson CE, Caplan JP. Zolpidemassociated parasomnia with serious self-injury: a shot in the dark. Psychosomatics. 2011;52(1):88–91.
5. Chong Y, Fryar CD, Gu Q. Prescription sleep aid use among adults: United States, 2005–2010. NCHS data brief, no 127. Hyattsville, MD: National Center for Health Statistics; 2013.
6. Huang MP, Radadia K, Macone BW, et al. Effects of eszopiclone and zolpidem on sleep-wake behavior, anxiety-like behavior, and contextual memory in rats. Behav Brain Res. 2010;210(1):54–66.
7. Schwartz LM, Woloshin S. Lost in transmission–FDA drug information that never reaches clinicians. N Engl J Med. 2009. 361(18): 1717-1720. doi: 10.1056/NEJMp0907708.
8. European Medicines Agency: EMEA/H/C/000895–Withdrawal Assessment for Lunivia 2009. EMA http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/2010/01/WC500061611.pdf. Accessed July 2015.
9. Holbrook AM, Crowther R, Lotter A, Cheng C, et al. Meta-analysis of benzodiazepine use in the treatment of insomnia. Can Med Assoc J. 2000;162(2):225–233.
10. Jerzy Cubala W, Gabrielsson A. Sleep related amnestic behaviors due to zolpidem. Bull Clin Psychopharmacol. 2014;24(2):189–194.
11. Smith KS, Engin E, Meloni EG, Rudolph U. Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABA(α) receptor subtypes in mice. Neuropharmacology. 2012.;63(2):250-258.
12. Dolder CR, Nelson MH. Hypnosedative-induced complex behaviours: incidence, mechanisms, and management. CNS Drugs. 2008;22(12):1021–1036.
13. Jones KA, Nielsen S, Bruno R, etal. Benzodiazepines: their role in aggression and why GPs should prescribe with caution. Aust Fam Physician. 2011;40(11):862–865.
14. Howell MJ. Parasomnias: an updated review. Neurotherapeutics. 2012;9(4):753–775.
15. Longo LP, Johnson B: Addiction: part I. benzodiazepines–side effects, abuse risk and alternatives. Am Fam Phys. 2000;61(7):2121–2128.
16. Tasman A, Kay J, Lieberman JA (eds). Psychiatry, 3rd ed, vol 1. Chichester, England: John Wiley & Sons: 2008;1186–1200, 2603–2615.
17. Zellner M, Watt D, Solms M, and Panksepp J. Affective neuroscientific and neuropsychoanalytic approaches to two intractable psychiatric problems: why depression feels so bad and what addicts really want. Neurosci Biobehav Rev. 2011;35(9):2000–2008.
18. Albrecht B, Staiger PK, Hall K, et al. Benzodiazepine use and aggressive behaviour: a systematic review. Aust N Z J Psychiatry. 2014;48(12):1096–1114.
19. Jansson-Frojmark M, Lindblom K. A bidirectional relationship between anxiety and depression, and insomnia? a prospective study in the general population. J Psychosom Res. 2008;64(4):443–449.
20. Masubuchi Y, Kawaguchi Y. Timedependent Inhibition of CYP3A4 by sertraline, a selective serotonin reuptake inhibitor. Biopharm Drug Dispos. 2013;34(8):423–430.
21. Najib J. Eszopiclone, a nonbenzodiazepine sedativehypnotic agent for the treatment of transient and chronic insomnia. Clin Ther. 2006;28(4):491–516.
22. Selvaraj V, Skaf M, Sharma A, et al. Eszopiclone-induced psychosis. Innov Clin Neurosci. 2012;9(10):11.
23. Ben-Hamou M, Marshall NS, Grunstein RR, et al. Spontaneous adverse event reports associated with zolpidem in Australia 2001–2008. J Sleep Res. 2011;20:559–568.
24. Mortaz Hejri S, Faizi M, Babeian M. Zolpidem-induced suicide attempt: a case report. Daru. 2013;21(77).